For clients producing biotech advancements in genomics and medical applications, Eric M. Brusca, Ph.D. secures patents internationally through prosecution and related proceedings. Clients rely on his legal experience from handling a wide variety of these technologies. They also gain sure and insightful assessments of their patentable products and processes, all rooted in his graduate training and research in microbiology, biochemistry and molecular biology. A teacher as well, he communicates effectively with his clients and successfully represents their interests.
Recent Client Work:
Successfully secured U.S. and foreign patents covering HPV vaccines, with an estimated market worth exceeding $3 billion annually.
Counseled, prepared, and prosecuted dozens of patent applications for clients working with recombinant DNA, protein and antibody technologies. Clients ranged from public and private universities and non-profit research institutions to "big pharma" companies worldwide.
Secured patents for industry-leading biotechnology companies covering recombinant blood clotting factors and recombinant growth factors.
Representative Experience:
Dr. Brusca has handled matters in a wide variety of biotechnology disciplines, such as:
Recombinant DNA;
Protein and antibody technology;
Gene therapy;
Growth factors;
Sequence analysis;
Vaccine development technology.
Background and Credentials:
Dr. Brusca has extensively assisted his biotech clients with domestic and foreign patent prosecution, U.S. interference and foreign opposition proceedings, and non-infringement/validity opinions.
He received his J.D. from The John Marshall Law School and has matched his legal experience with his mastery of various technologies. Prior to joining the firm, Dr. Brusca researched RNA-protein interactions and catalytic RNA molecules in the Department of Chemistry at Loyola University Chicago. He received his Ph.D. in Chemistry from Loyola University Chicago in 2001. Throughout his graduate studies, Dr. Brusca specialized in research topics pertaining to biochemistry, molecular biology and microbiology. He holds a M.S. in Microbiology from the University of Illinois at Urbana-Champaign.